You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Botulinum toxin for masseter hypertrophy
|
|---|---|
| Published in |
Cochrane database of systematic reviews, September 2013
|
| DOI | 10.1002/14651858.cd007510.pub3 |
| Pubmed ID | |
| Authors |
Zbys Fedorowicz, Esther J van Zuuren, Jan Schoones |
| Abstract |
Benign masseter muscle hypertrophy is an uncommon clinical phenomenon of uncertain aetiology which is characterised by a soft swelling near the angle of the mandible. The swelling may on occasion be associated with facial pain and can be prominent enough to be considered cosmetically disfiguring. Varying degrees of success have been reported for some of the treatment options for masseter hypertrophy, which range from simple pharmacotherapy to more invasive surgical reduction. Injection of botulinum toxin type A into the masseter muscle is generally considered a less invasive modality and has been advocated for cosmetic sculpting of the lower face. Botulinum toxin type A is a powerful neurotoxin which is produced by the anaerobic organism Clostridium botulinum and when injected into a muscle causes interference with the neurotransmitter mechanism producing selective paralysis and subsequent atrophy of the muscle.This review is an update of a previously published Cochrane review. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 203 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 1 | <1% |
| France | 1 | <1% |
| Ireland | 1 | <1% |
| Brazil | 1 | <1% |
| United Kingdom | 1 | <1% |
| Unknown | 198 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 30 | 15% |
| Student > Postgraduate | 20 | 10% |
| Researcher | 16 | 8% |
| Student > Doctoral Student | 16 | 8% |
| Student > Ph. D. Student | 12 | 6% |
| Other | 41 | 20% |
| Unknown | 68 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 96 | 47% |
| Agricultural and Biological Sciences | 9 | 4% |
| Nursing and Health Professions | 8 | 4% |
| Psychology | 4 | 2% |
| Biochemistry, Genetics and Molecular Biology | 3 | 1% |
| Other | 15 | 7% |
| Unknown | 68 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 September 2013.
All research outputs
#20,723,696
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#10,914
of 11,499 outputs
Outputs of similar age
#159,220
of 210,608 outputs
Outputs of similar age from Cochrane database of systematic reviews
#215
of 231 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,608 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 231 others from the same source and published within six weeks on either side of this one. This one is in the 2nd percentile – i.e., 2% of its contemporaries scored the same or lower than it.